[24-hour perfect BP-lowering therapy using long-acting dihydropyridine calcium channel blockers]

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Hypertension Management

Context:

• Antihypertensive treatment requires consistent blood pressure (BP) lowering.
• Dihydropyridine calcium channel blockers (CCBs) are effective antihypertensives associated with reduced cardiovascular events.
• Ambulatory BP monitoring reveals CCB effects on daytime, nighttime, and morning BP.

Purpose:

• To review the studies on long-acting dihydropyridine CCBs for comprehensive 24-hour BP management.
• To explore how CCBs influence circadian BP patterns, including nocturnal dipping status.
• To elucidate the mechanisms behind CCB's favorable cardiovascular outcomes.

Summary:

• Long-acting CCBs demonstrate consistent BP lowering throughout a 24-hour period.
• These agents can normalize abnormal nocturnal BP dipping patterns (e.g., non-dippers, risers) in hypertensive patients.
• CCBs reduce not only daytime but also nighttime and morning BP levels.

Impact:

• Understanding CCB effects on circadian BP patterns provides insight into their cardiovascular protective mechanisms.
• This review highlights the role of long-acting CCBs in achieving "24-hour perfect management of BP".
• Findings support the use of long-acting CCBs for improved hypertension control and cardiovascular risk reduction.